Outlook Therapeutics 株価情報 (NASDAQ: OTLK)

Outlook Therapeutics (NASDAQ:OTLK) 株価情報

Outlook Therapeutics

Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.

Outlook Therapeutics, Inc. - Common Stock

Outlook Therapeutics Inc

On Tuesday, Kraft Heinz Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KHC#NASDAQ">KHC</a>) reported its first-quarter 2025 earnings. The company houses popular brands like Oscar Mayer, Jell-O, Heinz Ketchup, lunchables and philadelphia cream cheese.
The food giant reported a <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/b45062374/kraft-heinz-reports-first-quarter-2025-results" rel="noreferrer noopener">sales decline of 6.4%</a> year-on-year to $5.99 billion, missing the analyst consensus estimate of $6.02 billion. Adjusted EPS of $0.62 <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">beat the consensus </a>estimate of $0.60.
Sales in North America declined by 7%, and International Developed Markets dropped by 4.4%. Organic net sales fell 4.7%.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/25/04/45039495/dominos-pizza-q1-operating-margin-shrinks-as-lower-income-consumers-feel-the-pinch" rel="noreferrer noopener">Domino's Pizza Q1 Operating Margin Shrinks As Lower-Income Consumers Feel the Pinch</a>
Gross profit decreased by 8% to $2.06 billion, with the margin contracted 60 points to 34.4%. The operating income for the quarter dropped 8.1% to $1.2 billion.
Selling, general and administrative expenses, declined 7.7% to $868 million.
As of March 29, Kraft Heinz held $2.11 billion in cash and equivalents. Year-to-date operating cash flow totaled $0.7 billion, with free cash flow of $0.5 billion.
As of March 29, the company had remaining authorization to repurchase approximately $1.7 billion of common stock under the publicly announced share repurchase program.&nbsp;
"We're closely monitoring the potential impacts from macro-economic pressures such as tariffs and inflation, and we are dedicated to increasing investments to drive product and brand superiority to deliver more value for our consumers," said CEO&nbsp;Carlos Abrams-Rivera.
"As the operating environment remains volatile, we are lowering our full-year outlook and expanding the range of our expectations to better reflect potential outcomes."
Kraft Heinz&nbsp;declared a <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/b45062413/the-kraft-heinz-company-declares-regular-quarterly-dividend-of-0-40-per-share" rel="noreferrer noopener">regular quarterly dividend of&nbsp;$0.40</a> per share of common stock payable on June 27, 2025, to stockholders&nbsp;of record as of May 30, 2025.
Outlook: Kraft Heinz lowered the FY25 adjusted EPS outlook from $2.63 &#8211; $2.74 to $2.51 &#8211; $2.67 versus an estimate of $2.67.
The company sees FY25 organic net sales to be down&nbsp;1.5% to 3.5% versus the prior year.
Price Action: KHC shares&nbsp;closed higher by 0.21% to $28.87 on Tuesday.
Read More:
<ul>
<li><a href="https://www.benzinga.com/news/25/04/45011035/meta-booz-allen-launch-space-llama-ai-system-for-space-station-operations" target="_blank" rel="noreferrer noopener">Meta, Booz Allen Launch' Space Llama' AI System For Space Station Operations</a></li>
</ul>
Photo by Jonathan Weiss via Shutterstock

Earnings

News

Guidance

General

Oscar Mayer And Jell-O Maker Kraft Heinz Feels Macro Economic Pinch, Cuts Profit Outlook

First Solar Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>) reported financial results for the first quarter after the market close on Tuesday. Here&#8217;s a look at the key performance highlights from the <a href="https://www.benzinga.com/pressreleases/25/04/b45082457/first-solar-inc-announces-first-quarter-2025-financial-results-and-revises-guidance-to-reflect-exp">first three months of the year</a>.
Q1 Earnings: First Solar reported first-quarter revenue of $844.57 million, beating analyst <a href="https://www.benzinga.com/calendars/earnings">estimates</a> of $839.28 million. Total revenue was down $700 million from the prior quarter, primarily driven by an anticipated seasonal reduction in module sales.
The solar company reported first-quarter earnings of $1.95 per share, missing analyst estimates of $2.63 per share, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>. The steep earnings miss appears to be weighing on the stock after hours. 
The company said cash, restricted cash, cash and restricted cash equivalents and marketable securities, less debt, decreased to $400 million at the end of the first quarter, down from $1.2 billion at the end of 2024.
&#8220;Despite the near-term challenges presented by the new tariff regime, we believe that the long-term&nbsp;outlook&nbsp;for solar demand, particularly in our core U.S. market, remains strong, and that First Solar remains well-positioned to serve this demand,&#8221; said Mark Widmar, CEO of First Solar
&#8220;This belief is based on the unique profile of First Solar compared to its peers, as America&#8217;s largest and most established solar module manufacturer, and the country&#8217;s only fully vertically integrated producer, our significant network of domestic supply chain vendors, and our proprietary CadTel-based semiconductor.&#8221;
Outlook: First Solar lowered its full-year outlook. The company now expects full-year 2025 revenue of $4.5 billion to $5.5 billion (previously $5.3 billion to $5.8 billion) versus estimates of $5.46 billion. The company now expects full-year earnings to come in at approximately $12.50 to $17.50 per share (previously $17 to $20 per share) versus estimates of $18.20 per share.
Soft guidance also appears to be partially responsible for the weakness in shares in extended trading. Management said it will provide more information on its conference call with investors and analysts, which got started at 4:30 p.m. ET.
FSLR Price Action: <a href="http://benzinga.com/quote/fslr">First Solar shares</a> were down about 21% heading into Tuesday&#8217;s print. The solar stock was down 10.51% after-hours, trading at $122.81 at the time of publication on Tuesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/25/04/45065410/exclusive-solarbank-to-develop-7-2-mw-solar-project-in-new-york">EXCLUSIVE: SolarBank To Develop 7.2 MW Solar Project In New York</a></li>
<li><a href="https://www.benzinga.com/25/04/44942759/gamestop-short-seller-andrew-left-goes-long-on-china-and-these-two-us-stocks-amid-the-market-correction-heres-more-on-it">GameStop Short Seller Andrew Left Goes Long On China And These 2 US Stocks Amid Market Correction</a></li>
</ul>
Photo: <a href="https://www.shutterstock.com/g/aroundtheworld">Around the World Photos</a>/Shutterstock.

After-Hours Center

Movers

FSLR

First Solar Falls Short On Q1 Earnings, Cuts FY Guidance Due To Tariffs, Shares Tumble

Mondelez International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDLZ#NASDAQ">MDLZ</a>) affirms FY2025 Adj EPS guidance from $3.02 to $3.02 vs $2.92 analyst estimate..

MDLZ

Mondelez International Affirms FY2025 Adj EPS to decline approximately 10% on a constant currency basis

WIIM

NVDA

Shares of chip stocks are trading lower after Super Micro Computer cut its preliminary guidance.

ONEOK shares are trading lower following a Q1 earnings miss.

Western Digital shares are trading higher in sympathy with Seagate, which rose after reporting Q3 earnings. Seagate said its guidance reflects minimal expected impact from global tariff policies.

Kadant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KAI#NYSE">KAI</a>) is looking for Q2 GAAP EPS of $1.89-$1.99 vs $2.70 analyst estimate..

Kadant Sees Q2 GAAP EPS $1.89-$1.99 vs $2.70 Est

Kadant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KAI#NYSE">KAI</a>) lowers FY2025 Adj EPS guidance from $9.70-$10.05 to $9.05-$9.25 vs $9.94 analyst estimate. Lowers FY2025 sales outlook from $1.04 billion-$1.06 billion to $1.02 billion-$1.04 billion vs $1.05 billion estimate.

Kadant Lowers FY2025 Adj EPS Guidance from $9.70-$10.05 to $9.05-$9.25 vs $9.94 Est; Lowers FY2025 Sales Guidance from $1.04B-$1.06B to $1.02B-$1.04B vs $1.05B Est

Kadant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KAI#NYSE">KAI</a>) lowers FY2025 GAAP EPS guidance from $9.63-$9.98 to $8.97-$9.17 vs $10.15 analyst estimate..

Kadant Lowers FY2025 GAAP EPS Guidance from $9.63-$9.98 to $8.97-$9.17 vs $10.15 Est

Kadant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KAI#NYSE">KAI</a>) is looking for Q2 Adj EPS of $1.90-$2.00 vs $2.61 analyst estimate. sees sales of $243.000 million-$250.000 million vs $266.12 million analyst estimate.

Kadant Sees Q2 Adj EPS $1.90-$2.00 vs $2.61 Est; Sees Sales $243.000M-$250.000M vs $266.12M Est

Orion Gr Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORN#NYSE">ORN</a>) affirms FY2025 Adj EPS guidance from $0.11-$0.17 to $0.11-$0.17 vs $0.24 analyst estimate. sees sales of $800.000 million-$850.000 million vs $816.52 million analyst estimate.

Orion Gr Hldgs Affirms FY2025 Adj EPS Guidance of $0.11-$0.17 vs $0.24 Est; Sees Sales $800.000M-$850.000M vs $816.52M Est

CoStar Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSGP#NASDAQ">CSGP</a>) sees Q2 sales of $770.000 million-$775.000 million vs $786.94 million analyst estimate.

CSGP

CoStar Group Sees Q2 Revenue range of $770.000M-$775.000M vs $786.94M Est

Management

ACEL

Accel Entertainment Announced That Mathew Ellis, Chief Financial Officer, Has Resigned, Effective May 9, 2025; Mark Phelan Appointed As Acting Chief Financial Officer

CoStar Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSGP#NASDAQ">CSGP</a>) raises FY2025 sales outlook from $2.98 billion-$3.02 billion to $3.12 billion-$3.15 billion vs $3.15 billion estimate.

CoStar Group Raises FY2025 revenue Guidance from $2.98B-$3.02B to $3.12B-$3.15B vs $3.15B Est

Vertex Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>) has outperformed the market over the past 10 years by 4.96% on an annualized basis producing an average annual return of 15.22%. Currently, Vertex Pharmaceuticals has a market capitalization of $129.20 billion. 
Buying $1000 In VRTX: If an investor had bought $1000 of VRTX stock 10 years ago, it would be worth $3,986.54 today based on a price of $503.15 for VRTX at the time of writing.
<h3>Vertex Pharmaceuticals's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745959511_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

VRTX

$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today

Kadant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KAI#NYSE">KAI</a>) reported quarterly earnings of $2.10 per share which beat the analyst consensus estimate of $1.97 by 6.6 percent. This is a 11.76 percent decrease over earnings of $2.38 per share from the same period last year. The company reported quarterly sales of $239.21 million which missed the analyst consensus estimate of $239.41 million by 0.09 percent. This is a 3.92 percent decrease over sales of $248.97 million the same period last year.

Earnings Beats

Earnings Misses

Kadant Q1 Adj. EPS $2.10 Beats $1.97 Estimate, Sales $239.21M Miss $239.41M Estimate

VICR

Vicor shares are trading lower after the company reported worse-than-expected Q1 financial results.

Rosenblatt analyst Barton Crockett initiated coverage on Viant Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DSP#NASDAQ">DSP</a>) on Tuesday <a target="_blank" href="https://www.benzinga.com/quote/DSP/analyst-ratings" rel="noreferrer noopener">with a Buy rating and price forecast of $20.</a>
Crockett suggests that although Viant is much smaller than The Trade Desk, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTD#NASDAQ">TTD</a>), its innovative approach positions it well in the growing AdTech space.
U.S.-focused Viant stands out with its Household ID identity graph, which maps people and devices within homes to improve ad targeting—reaching 80% of the bid stream, up 50% year-over-year. Unlike traditional identifiers like UID 2.0, Viant's model enhances addressability and is backed by its unique Conversion Lift analysis to measure the true impact of ad campaigns.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/04/44673238/apple-faces-eps-hit-from-tariffs-while-doubleverify-and-viant-stay-shielded-with-virtual-revenue-models-analyst" rel="noreferrer noopener">Analyst Forecasts Tariffs Impact On Apple&#8217;s Profit And Highlights 2 Software Stocks That Are Safeguards</a>
The analyst notes that while macro risks from potential tariff wars remain, Viant's past challenges—such as the 2022 ad market slowdown that led to pulled guidance and a 12% drop in contribution excluding TAC—highlight the sector's vulnerability.
However, with a 15% rebound in 2023 and expectations that Trump may ease trade tensions to stabilize the economy, the ad outlook could improve. Viant is also seen as less exposed to high-risk segments, with minimal reliance on auto ads and a stronger focus on sectors like healthcare. The company remains optimistic about near-term trends.
Overall, the analyst highlights Viant's focus on a structurally growing segment, supported by innovations like its household-based identity graph and tools that measure the incremental value of CTV and other ad views.
Additionally, Viant may gain from any regulatory action stemming from the AdTech antitrust case against Google, particularly if it leads to market reforms, Crockett writes.
Price Action: DSP shares are trading higher by 2.73% to $14.70 at last check on Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/45078739/stocks-surge-and-bond-yields-fall-for-6th-day-oil-prices-drop-to-60-whats-driving-markets-tuesday" target="_blank" rel="noreferrer noopener">Stocks Surge And Bond Yields Fall For 6th Day, Oil Prices Drop To $60: What&#8217;s Driving Markets Tuesday?</a></li>
</ul>
Photo: Shutterstock

Equities

Markets

Analyst Ratings

Viant Gains Analyst Praise For Household ID, CTV Tools Amid Ad Market Rebound

PPG Industries shares are trading higher after the company reported better-than-expected Q1 financial results.

ONEOK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKE#NYSE">OKE</a>) affirms FY2025 GAAP EPS guidance from $5.37 to $5.37 vs $5.52 analyst estimate..

ONEOK Affirms FY2025 GAAP EPS Guidance of $5.37 vs $5.52 Est

Press Releases

Outlook Therapeutics® Announces Complete Twelve Week Efficacy and Safety Results of NORSE EIGHT Clinical Trial

Outlook Therapeutics® to Present at LIVE! with Webull Corporate Connect: Healthcare Investment Webinar

Outlook Therapeutics® Announces Presentation of Efficacy and Safety Results from NORSE EIGHT Clinical Trial Evaluating ONS-5010 for the Treatment of Wet AMD

Comments

Outlook Therapeutics

ニュース

パートナーシップ

ベンジンガ・グローバル